Assay method development
The company develops customized methods for LC-MS/MS and ligand-binding assays.
Source: LinkedIn company description · Retrieved November 17, 2026

Swiss BioQuant is a bioanalytical contract research organization specializing in LC-MS/MS and ligand-binding assays.
The company offers customized LC-MS/MS and ligand-binding assay method development, validation, and sample analysis. Its stated service environment is 21 CFR Part 11 compliant and covers small and large molecules.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Swiss BioQuant serves pharmaceutical and biotechnology companies.
The company develops customized methods for LC-MS/MS and ligand-binding assays.
Source: LinkedIn company description · Retrieved November 17, 2026
The company provides validation and sample analysis in a 21 CFR Part 11 compliant environment for small and large molecules.
Source: LinkedIn company description · Retrieved November 17, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on November 17, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 18, 2026. Directory positions use company-contact counts from separate saved list snapshots dated November 5, 2026 and November 6, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.